Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
82.78 USD | +6.74% | +7.30% | +24.32% |
Financials (USD)
Sales 2024 * | 5.26B | Sales 2025 * | 5.7B | Capitalization | 7.78B |
---|---|---|---|---|---|
Net income 2024 * | 396M | Net income 2025 * | 441M | EV / Sales 2024 * | 1.95 x |
Net Debt 2024 * | 2.47B | Net Debt 2025 * | 2.36B | EV / Sales 2025 * | 1.78 x |
P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
18.1
x | Employees | 23,832 |
Yield 2024 * |
0.77% | Yield 2025 * |
0.77% | Free-Float | 85.22% |
Latest transcript on Encompass Health Corporation
1 day | +1.26% | ||
1 week | +1.36% | ||
Current month | +4.45% | ||
1 month | +3.15% | ||
3 months | +15.04% | ||
6 months | +15.79% | ||
Current year | +16.47% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 62 | 92-12-31 |
Douglas Coltharp
DFI | Director of Finance/CFO | 63 | 10-05-05 |
Chief Tech/Sci/R&D Officer | 64 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslye Katz
BRD | Director/Board Member | 69 | 13-01-24 |
Director/Board Member | 61 | 19-12-31 | |
Mark Tarr
CEO | Chief Executive Officer | 62 | 92-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.44% | 8 M€ | +6.91% | ||
1.39% | 2 M€ | +12.97% | ||
1.09% | 231 M€ | -1.00% | ||
1.09% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 82.74 | +6.69% | 309 785 |
24-03-27 | 77.71 | +1.26% | 444,070 |
24-03-26 | 76.74 | +0.79% | 410,258 |
24-03-25 | 76.14 | -0.48% | 465,270 |
24-03-22 | 76.51 | -1.02% | 689,457 |
Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.47% | 7.78B | |
-19.03% | 16.53B | |
-10.94% | 15.21B | |
+2.70% | 12.44B | |
0.00% | 11.22B | |
+11.69% | 10.75B | |
+7.41% | 8.39B | |
+21.11% | 7.22B | |
+11.95% | 7.15B | |
+3.61% | 4.64B |